Drugs / Lopinavir 200Mg/Ritonavir 50Mg Tab
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04365582 | May → Dec 2020 | COVID-19 | Fondation Hôpital Saint-Joseph | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Lopinavir 200Mg/Ritonavir 50Mg Tab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04365582 ↗ |